Compare ELME & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELME | NEOG |
|---|---|---|
| Founded | 1960 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | N/A | 1989 |
| Metric | ELME | NEOG |
|---|---|---|
| Price | $17.30 | $5.91 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $15.00 | $8.83 |
| AVG Volume (30 Days) | 1.5M | ★ 3.6M |
| Earning Date | 10-23-2025 | 01-09-2026 |
| Dividend Yield | ★ 4.16% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $246,959,000.00 | ★ $886,886,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.10 | N/A |
| 52 Week Low | $13.95 | $3.87 |
| 52 Week High | $18.08 | $14.26 |
| Indicator | ELME | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 68.52 | 46.94 |
| Support Level | $16.38 | $5.85 |
| Resistance Level | $17.40 | $6.22 |
| Average True Range (ATR) | 0.18 | 0.35 |
| MACD | 0.07 | -0.03 |
| Stochastic Oscillator | 92.65 | 38.15 |
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.